Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henrik Fox

Showing results (121-130 of 130) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 130 results.
Resuscitation|August 14, 2021
The emergency medical service has a crucial role to unravel the genetics of sudden cardiac arrest in young, out of hospital resuscitated patients: Interim data from the MAP-IT studyJens Tiesmeier, Anna Gaertner, Sören Homm, et al.
Heart Rhythm|April 11, 2024
Prognosis of patients in end-stage heart failure with atrial fibrillation treated with ablation: Insights from CASTLE-HTxMaximilian Moersdorf, Jan G P Tijssen, Nassir F Marrouche, et al.
European Journal of Heart Failure|October 24, 2024
Effects of atrial fibrillation ablation on arrhythmia burden and ventricular function in end-stage heart failure: Lessons from CASTLE-HTxVanessa Sciacca, Christian Sohns, Harry J G M Crijns, et al.
The New England Journal of Medicine|August 27, 2023
Catheter Ablation in End-Stage Heart Failure with Atrial FibrillationChristian Sohns, Henrik Fox, Nassir F Marrouche, et al.
Circulation|August 30, 2024
Catheter Ablation in Patients With End-Stage Heart Failure and Atrial Fibrillation: Two-Year Follow-Up of the CASTLE-HTx TrialChristian Sohns, Maximilian Moersdorf, Nassir F Marrouche, et al.
Heart Rhythm|May 20, 2026
Cost-Effectiveness of Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation: Insights from CASTLE-HTxPriyanka Boettger, Maximilian Moersdorf, Philipp Sommer, et al.
Circulation|August 31, 2025
3-Year Outcomes of Catheter Ablation in Patients with End-Stage Heart Failure and Atrial FibrillationChristian Sohns, Maximilian Moersdorf, Nassir F Marrouche, et al.
JACC. Heart Failure|August 14, 2025
Sex and Treatment Outcomes of Atrial Fibrillation Ablation in End-Stage Heart Failure: Insights From CASTLE-HTxThomas Fink, Maximilian Moersdorf, Angelika Costard-Jaeckle, et al.
International Journal of Legal Medicine|February 11, 2023
Blood taken immediately after fatal resuscitation attempts yields higher quality DNA for genetic studies as compared to autopsy samplesCaroline Stanasiuk, Hendrik Milting, Sören Homm, et al.
Science (New York, N.Y.)|August 4, 2022
Pathogenic variants damage cell composition and single cell transcription in cardiomyopathiesDaniel Reichart, Eric L Lindberg, Henrike Maatz, et al.
Pageof 13

Showing results (121-130 of 130) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 130 results.
Resuscitation|August 14, 2021
The emergency medical service has a crucial role to unravel the genetics of sudden cardiac arrest in young, out of hospital resuscitated patients: Interim data from the MAP-IT studyJens Tiesmeier, Anna Gaertner, Sören Homm, et al.
Heart Rhythm|April 11, 2024
Prognosis of patients in end-stage heart failure with atrial fibrillation treated with ablation: Insights from CASTLE-HTxMaximilian Moersdorf, Jan G P Tijssen, Nassir F Marrouche, et al.
European Journal of Heart Failure|October 24, 2024
Effects of atrial fibrillation ablation on arrhythmia burden and ventricular function in end-stage heart failure: Lessons from CASTLE-HTxVanessa Sciacca, Christian Sohns, Harry J G M Crijns, et al.
The New England Journal of Medicine|August 27, 2023
Catheter Ablation in End-Stage Heart Failure with Atrial FibrillationChristian Sohns, Henrik Fox, Nassir F Marrouche, et al.
Circulation|August 30, 2024
Catheter Ablation in Patients With End-Stage Heart Failure and Atrial Fibrillation: Two-Year Follow-Up of the CASTLE-HTx TrialChristian Sohns, Maximilian Moersdorf, Nassir F Marrouche, et al.
Heart Rhythm|May 20, 2026
Cost-Effectiveness of Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation: Insights from CASTLE-HTxPriyanka Boettger, Maximilian Moersdorf, Philipp Sommer, et al.
Circulation|August 31, 2025
3-Year Outcomes of Catheter Ablation in Patients with End-Stage Heart Failure and Atrial FibrillationChristian Sohns, Maximilian Moersdorf, Nassir F Marrouche, et al.
JACC. Heart Failure|August 14, 2025
Sex and Treatment Outcomes of Atrial Fibrillation Ablation in End-Stage Heart Failure: Insights From CASTLE-HTxThomas Fink, Maximilian Moersdorf, Angelika Costard-Jaeckle, et al.
International Journal of Legal Medicine|February 11, 2023
Blood taken immediately after fatal resuscitation attempts yields higher quality DNA for genetic studies as compared to autopsy samplesCaroline Stanasiuk, Hendrik Milting, Sören Homm, et al.
Science (New York, N.Y.)|August 4, 2022
Pathogenic variants damage cell composition and single cell transcription in cardiomyopathiesDaniel Reichart, Eric L Lindberg, Henrike Maatz, et al.
Pageof 13